For sustainable recovery from the COVID-19 global economic shock, it’s imperative to break from policy choices that produce a concentration of economic power and wealth in a limited section of the economy but old habits, die hard warns UNCTAD’s Richard Kozul-Wright.
The governments of India and South-Africa backed by about 100 countries and counting are calling for a waiver on patents over COVID-19 related medicines and equipment. Headquarter countries of Big Pharma are opposing it. The debate is going on at the WTO and will be decided soon.
